FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:96-97 July 3, 2003 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

To the Editor: Recreational use of 3,4-methylenedioxymethamphetamine (MDMA), or "ecstasy," has been increasing. MDMA has classically been associated with serotonergic neurotoxicity in humans and in animal models. Recent investigations in nonhuman primates, at doses modeled after those used by humans, revealed severe dopaminergic neurotoxicity with less serotonergic neurotoxicity.¹ We report a case of juvenile Parkinson's disease after repeated use of MDMA.

A 19-year-old man was observed to have a resting tremor in his right hand on going to sleep and waking from a nap in March 2002. The tremor progressed to affect the right leg. Magnetic resonance imaging of the . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.